• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Envigo appoints Scott Schulz Director of North American Operations

Envigo appoints Scott Schulz Director of North American Operations

May 26, 2016
CenterWatch Staff

Envigo has appointed Scott Schulz, MBA, to the post of director, North American (NA) Operations. In this role, Schulz will optimize operational performance and service delivery across the company’s North American based production locations for Research Models and Services (RMS). He will report directly to Michael Caulfield, president North American RMS at Envigo.

Schulz will serve as the operational leader of the North American Leadership Team. He has management responsibility for Research Models North American animal production facilities and will drive continuous improvement while ensuring the consistent availability of models to meet customer demand in full. His direction of operational performance will include best-in-class quality, high levels of productivity, animal welfare with a focus on health status and genetics, and fulfilling customer requirements.

Prior to joining Envigo, Schulz served as vice president of Operations at Taconic Biosciences, where he introduced lean manufacturing methodologies including 5S and process mapping and also established a continuous improvement culture through the development of a Lean Six Sigma training programme. When a director of Operations at Baxter Health, Schulz led 300 production team members engaged in the manufacture of aseptically filled injectable medication and medical devices for enterprise clients, including major pharmaceutical and biotech companies, and internal customers. Previously, as a senior director of manufacturing operations at Cardinal Health, Schulz was responsible for the effective management of a $160 million production operation and over 400 employees.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing